Michael J. Droller

7.7k total citations
176 papers, 5.6k citations indexed

About

Michael J. Droller is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michael J. Droller has authored 176 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Surgery, 41 papers in Pulmonary and Respiratory Medicine and 32 papers in Oncology. Recurrent topics in Michael J. Droller's work include Bladder and Urothelial Cancer Treatments (105 papers), Urinary and Genital Oncology Studies (60 papers) and Urological Disorders and Treatments (23 papers). Michael J. Droller is often cited by papers focused on Bladder and Urothelial Cancer Treatments (105 papers), Urinary and Genital Oncology Studies (60 papers) and Urological Disorders and Treatments (23 papers). Michael J. Droller collaborates with scholars based in United States, Canada and Germany. Michael J. Droller's co-authors include Shahrokh F. Shariat, Brian C.‐S. Liu, Peter Perlmann, Yves Fradet, H. Barton Grossman, M Schneider, Richard Lee, Elizabeth Kavaler, Jaime Landman and Pierre I. Karakiewicz and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael J. Droller

164 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Droller United States 37 3.5k 1.3k 1.0k 993 926 176 5.6k
Michael Stöckle Germany 42 3.2k 0.9× 2.1k 1.7× 975 0.9× 3.1k 3.1× 1.1k 1.2× 287 7.0k
F. K. Mostofi United States 39 3.4k 1.0× 1.3k 1.0× 766 0.7× 2.4k 2.4× 1.4k 1.5× 90 6.2k
Ralph W. deVere White United States 44 2.9k 0.8× 3.2k 2.5× 1.5k 1.5× 2.2k 2.2× 1.1k 1.2× 159 7.7k
Kátia Ramos Moreira Leite Brazil 33 924 0.3× 1.7k 1.3× 759 0.7× 1.3k 1.3× 359 0.4× 306 4.2k
Toshiyuki Kamoto Japan 37 788 0.2× 1.4k 1.1× 840 0.8× 1.6k 1.6× 386 0.4× 262 3.9k
Nam Hoon Cho South Korea 38 1.0k 0.3× 1.8k 1.4× 1.3k 1.2× 1.2k 1.2× 179 0.2× 223 4.9k
Nicolas Wernert Germany 42 840 0.2× 2.5k 2.0× 1.0k 1.0× 1.3k 1.3× 203 0.2× 154 5.2k
Raymond B. Nagle United States 48 1.2k 0.3× 3.0k 2.4× 2.8k 2.7× 2.1k 2.1× 325 0.4× 174 8.6k
Harald Schulze Germany 38 746 0.2× 1.4k 1.1× 380 0.4× 1.2k 1.2× 288 0.3× 150 5.1k
Carlos Lopes Portugal 47 1.3k 0.4× 2.8k 2.2× 1.8k 1.7× 2.4k 2.4× 133 0.1× 195 6.6k

Countries citing papers authored by Michael J. Droller

Since Specialization
Citations

This map shows the geographic impact of Michael J. Droller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Droller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Droller more than expected).

Fields of papers citing papers by Michael J. Droller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Droller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Droller. The network helps show where Michael J. Droller may publish in the future.

Co-authorship network of co-authors of Michael J. Droller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Droller. A scholar is included among the top collaborators of Michael J. Droller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Droller. Michael J. Droller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dyrskjøt, Lars, Antonia Vlahou, Peter C. Black, et al.. (2022). 25 years International Bladder Cancer Network (IBCN): The past, the present, and the future. Urologic Oncology Seminars and Original Investigations. 41(7). 302–306. 1 indexed citations
2.
Willis, Daniel, Thomas W. Flaig, Donna E. Hansel, et al.. (2014). Micropapillary bladder cancer: Current treatment patterns and review of the literature. Urologic Oncology Seminars and Original Investigations. 32(6). 826–832. 43 indexed citations
3.
Schmitz‐Dräger, Bernd J., Michael J. Droller, Vinata B. Lokeshwar, et al.. (2014). Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus. Urologia Internationalis. 94(1). 1–24. 118 indexed citations
4.
Zlotta, Alexandre R., Samuel M. Cohen, Colin P. Dinney, et al.. (2010). BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer. Urologic Oncology Seminars and Original Investigations. 28(3). 329–333. 4 indexed citations
5.
Shariat, Shahrokh F., Guilherme Godoy, Yair Lotan, et al.. (2009). Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy. British Journal of Urology. 105(12). 1672–1677. 89 indexed citations
6.
Lokeshwar, Vinata B., Tomonori Habuchi, H. Barton Grossman, et al.. (2005). Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology. 66(6). 35–63. 306 indexed citations
7.
Habuchi, Tomonori, Michael Marberger, Michael J. Droller, et al.. (2005). Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology. 66(6). 64–74. 128 indexed citations
8.
Helpap, B., Bernd J. Schmitz‐Dräger, Peter W. Hamilton, et al.. (2003). Molecular pathology of non-invasive urothelial carcinomas (part I). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 442(4). 309–316. 32 indexed citations
9.
Canfield, Steven E., Colin P. Dinney, & Michael J. Droller. (2003). Surveillance and management of recurrence for upper tract transitional cell carcinoma. Urologic Clinics of North America. 30(4). 791–802. 18 indexed citations
10.
Lehrer, Steven, John Roboz, Hu Ding, et al.. (2003). Putative protein markers in the sera of men with prostatic neoplasms. British Journal of Urology. 92(3). 223–225. 49 indexed citations
11.
Droller, Michael J.. (2002). Current concepts of tumor markers in bladder cancer. Urologic Clinics of North America. 29(1). 229–234. 9 indexed citations
12.
Brawer, Michael K., Thomas A. Stamey, Jackson E. Fowler, et al.. (2001). Perspectives on prostate cancer diagnosis and treatment: a roundtable. Urology. 58(2). 135–140. 4 indexed citations
13.
Hassen, Waleed & Michael J. Droller. (2000). Current concepts in assessment and treatment of bladder cancer. Current Opinion in Urology. 10(4). 291–299. 28 indexed citations
14.
Droller, Michael J.. (1998). Bladder cancer: state-of-the-art care. CA A Cancer Journal for Clinicians. 48(5). 269–284. 99 indexed citations
15.
Droller, Michael J.. (1997). Medical approaches in the management of prostatic disease. British Journal of Urology. 79(S2). 42–52. 14 indexed citations
16.
Landman, Jaime, Elizabeth Kavaler, Michael J. Droller, & Brian C.‐S. Liu. (1997). Applications of telomerase in urologic oncology. World Journal of Urology. 15(2). 120–124. 14 indexed citations
17.
Droller, Michael J.. (1990). Anatomic considerations in extraperitoneal approach to radical nephrectomy. Urology. 36(2). 118–123. 6 indexed citations
18.
Schwartz, Gary K., et al.. (1990). Inhibition of Invasion of Invasive Human Bladder Carcinoma Cells by Protein Kinase C Inhibitor Staurosporine. JNCI Journal of the National Cancer Institute. 82(22). 1753–1756. 85 indexed citations
19.
Tannenbaum, Myron, et al.. (1988). Muscle-invasive bladder cancer: Does it arise de novo or from pre-existing superfacial disease?. Urology. 32(1). 58–62. 9 indexed citations
20.
Droller, Michael J.. (1986). Therapy and Prophylaxis of Superficial Bladder Carcinomas. The Journal of Urology. 135(6). 1347–1348. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Stöckle Breakdown of academic impact, for papers by F. K. Mostofi Breakdown of academic impact, for papers by Ralph W. deVere White Breakdown of academic impact, for papers by Kátia Ramos Moreira Leite Breakdown of academic impact, for papers by Toshiyuki Kamoto Breakdown of academic impact, for papers by Nam Hoon Cho Breakdown of academic impact, for papers by Nicolas Wernert Breakdown of academic impact, for papers by Raymond B. Nagle Breakdown of academic impact, for papers by Harald Schulze Breakdown of academic impact, for papers by Carlos Lopes
Rankless by CCL
2026